Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02775734

NAC in CC Resistant PCOS After LOD (NAC)

N-acetyl-cysteine in Clomiphene Citrate Resistant Polycystic Ovary Syndrome After Laparoscopic Ovarian Drilling: A Randomized Controlled Trial

Sponsor: Ain Shams University

Conditions Clomiphene Citrate Resistant Polycystic Ovary Syndrome

Interventions Clomiphene citrate N-acetyl-cysteine

Updated 7 times since 2017 Last updated: Apr 28, 2017 Started: May 31, 2016 Primary completion: Mar 31, 2017 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02775734, this PHASE2/PHASE3 trial focuses on Clomiphene Citrate Resistant Polycystic Ovary Syndrome and remains completed. Sponsored by Ain Shams University, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jun 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

Status: Recruiting → Completed

▶ Show 2 earlier versions

Feb 2017 — Jun 2017 [monthly]

Recruiting PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2_PHASE3

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt